Patents/Assignees

Enanta Pharmaceuticals, Inc.

44 patents in portfolio

US11578097utility2023
Tetrazole Derivatives of Bile Acids as FXR/TGR5 Agonists and Methods of Use Thereof
0 cites
US11572367utility2023
Antiviral Heterocyclic Compounds
0 cites
US11560368utility2023
Apoptosis Signal-regulating Kinase 1 Inhibitors and Methods of Use Thereof
0 cites
US11555032utility2023
Isoxazole Derivatives as FXR Agonists and Methods of Use Thereof
0 cites

← PreviousPage 3 of 3